Arcadia Biosciences, Inc. — Cyborg Score 3/10

Strategic Profile

The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Product offerings include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring, positioning it across multiple consumer health segments.

Cyborg Score Rationale

The company's market capitalization stands at $5.24M with minimal trading volume. As of October 2025, the company has only 9 employees, and EBITDA is negative at −8.74M USD with a negative margin of −96.08%.

Top Insights

• Extremely small market capitalization ($5.24M) suggests limited investment liquidity and significant volatility risk
• Recent Q3 2025 earnings showed surprising profitability with $0.63 EPS, beating estimates significantly despite prior losses
• Company operates with skeleton crew of 9 employees, likely leveraging partnerships for manufacturing and distribution
• Diversified product portfolio across beverages (Zola), grains (GoodWheat), and wellness (ProVault) may dilute focus and resources

Named Competitors

• Vita Coco Coconut Water — Leading coconut water brand with global distribution
• Simply Almond — Plant-based beverage from major CPG conglomerate
• Orgain Plant-Based Products — Diversified plant-based nutrition company

Recent Developments

• (November 2025) Q3 2025 earnings reported EPS of $0.63, beating analyst estimates of -$0.54 by 216.67%
• (2024) Company transitioned leadership; investigations into proposed mergers suggest corporate activity
• (2024-2025) Announced strategic asset sales including non-GMO Resistant Starch product line

Open the full interactive Arcadia Biosciences, Inc. report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.